Mesothelioma is the most serious of all asbestos-related diseases. In the past four years, 12,000 people have died from mesothelioma in the United States and another 3,000 or more people will be diagnosed with mesothelioma this year. Our legal team includes exceptional attorneys with a broad medical knowledge as well as paralegals and nurse legal assistants working together to represent our clients with compassion and understanding as well as legal excellence.

I have an asbestos disease and want to file a lawsuit, what should I do? You need to contact a mesothelioma lawyer as soon as possible because every state has a statute of limitations. The statute of limitations outlines a specific time period in which you can file a lawsuit and if you do not act promptly, your window of opportunity may expire. This amount of time varies from state to state.

The National Cancer Institute states that: "Malignant mesothelioma, a rare form of cancer, is a disease in which cancer (malignant) cells are found in the sac lining the chest (the pleura), the lining of the abdominal cavity (the peritoneum) or the lining around the heart (the pericardium)." Most people with malignant mesothelioma have worked on jobs where they breathed asbestos. Others have been exposed to asbestos in a household environment, often without knowing it. An exposure of as little as one or two months can result in mesothelioma 30 or 40 years later.

The UAB Comprehensive Cancer Center can provide you with personalized, expert cancer diagnosis and treatment. A caring and devoted team of researchers and physicians are working together to gain the latest molecular insights into cancer and bring the most innovative therapies to patients.

Mesothelioma Clinical Trials. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research.

General Information, Cellular Classification, Stage Information, Treatment Option Overview, Localized Malignant Mesothelioma (Stage I), Advanced Malignant Mesothelioma (Stages II, III, and IV), Recurrent Malignant Mesothelioma. Prognosis in this disease is difficult to assess consistently because there is great variability in the time before diagnosis and the rate of disease progression.

The Rebecca and John Moores UCSD Cancer Center is located at the University of California, San Diego. Founded in 1979, the Moores UCSD Cancer Center is one of just 39 centers in the United States to hold a National Cancer Institute (NCI) designation as a Comprehensive Cancer Center. As such, it ranks among the top centers in the nation conducting basic and clinical cancer research, providing advanced patient care and serving the community through outreach and education programs.

Founded in 1960. Today, UCLA's Jonsson Comprehensive Cancer Center (JCCC) has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments, and expertly guiding and training the next generation of medical researchers.

The USC/Norris Comprehensive Cancer Center is a leader in cancer research, with nearly 200 members investigating the complex origins and progression of cancer, developing prevention strategies and searching for cures. USC/Norris is designated by the National Cancer Institute as one of the nation's 39 comprehensive cancer centers.

This guide will help you to look for a cancer treatment clinical trial that might benefit you. It is not intended to provide medical advice. You, your health care team, and your loved ones are in the best position to decide whether a clinical trial is right for you. This guide will help you to: gather the information you need to begin your search for a clinical trial, identify sources of clinical trial listings, learn about clinical trials that may be of benefit to you, ask questions that will help you decide whether or not to participate in a particular trial.